A detailed history of Mountain Pacific Investment Advisers Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 385 shares of LLY stock, worth $290,675. This represents 0.02% of its overall portfolio holdings.

Number of Shares
385
Previous 385 -0.0%
Holding current value
$290,675
Previous $348,000 2.01%
% of portfolio
0.02%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$525.19 - $619.13 $13,129 - $15,478
-25 Reduced 6.1%
385 $224,000
Q3 2023

Oct 20, 2023

BUY
$434.7 - $599.3 $178,227 - $245,712
410 New
410 $220,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mountain Pacific Investment Advisers Inc Portfolio

Follow Mountain Pacific Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.